Live Breaking News & Updates on Nih study

Stay informed with the latest breaking news from Nih study on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Nih study and stay connected to the pulse of your community

CNN News Central

researcherings to do this big study. because there were 150 reports of the people taking the drug name for these or similar medicines who had suicidal thoughts, and so you the look into the case reports like that, and similarly in the united states. the fda had case reports of them in the database, and just this week, they were looking into 44 cases this week, and looking into a link, but so far they have not established one, but the reviews are ongoing. >> based on the nih study, is it is possible that it means that ozempic and wegovy may actually help mental health? >> we are seeing the medicines tested for more and more thing, and the way they work is not just in the gut to slow down the digestion, and that, but they have effects in the brain. is there is a question here if they could help with something like depression, and there is at least one clinical trial going on the assess it now, and the

People , Study , Name , U-s- , Medicines , Look , Case-reports , Thoughts , Drug , Similarly , Researcherings , 150

The Lead With Jake Tapper

but they did that study during delta. not omicron. maybe it's higher now. let's look at an nih study. they said it is more like 5.4%, which is much larger than 2%. once you think of the people you know personally, i certainly know people. people we know who are out in the public sphere. president biden has had rebound. his wife dr. jill biden had rebound, dr. anthony fauci, stephen coatbert. all of them took paxlovid and had rebound. dr. jonathan reiner, they had paxlovid rebound. one of the theories here is that what is going on is you only take it for five days. and one of the theories is maybe that length should have been longer. the fda has asked for more data on this. >> so we'll see if we get more data on that. meantime, when it does come to paxlovid, who should be taking it? especially if there are these rebound cases.

Study , Nih-study , Not-omicron , Delta , 5-4 , President , People , Rebound , Jill-biden , Wife , Public-sphere , Stephen-coatbert

CNN Newsroom With Ana Cabrera-20211209-18:38:00

>> mouthwash has been proven to kill the coronavirus, you need to get it if you may reduce the viral, why not try all of these things. >> he's talking about mouthwash. we asked about the comments, and johnson said he was referencing an nih study that mouthwash can help reduce viral replication, and has he says his comments were taken out of context, what's your reaction? >> well, let's think, there are an awful lot of bright people out there who have great ideas that are working in the laboratories to try to figure out ways we can better treat and prevent covid. and yes, there is a study in the petri dish that shows that a certain kind of mouthwash can inhibit the replication of the virus, that doesn't mean we should all go out and gargle. we have to see clinical trials,

All , Things , Mouthwash , Viral , Coronavirus , Reaction , Context , Comments , Ron-johnson , Replication , Nih-study , People

Alex Witt Reports-20211024-18:41:00

"meet the press," dr. rochelle walensky addressed booster shot confusion. >> we saw data from the nih on mix and match that antibody levels for mixing and matching were very high. if you're boosted with j&j, you actually do quite well as well. any one of these vaccines can really be used to boost any one of the others. >> joining me now nbc news medical contributor. good to see you, my friend. lots of questions. millions more people are eligible for boosters. so how do you decide which one to get? is it better to get a different vaccine? and where do you go to either get it or get the information you need? >> alex, i think what i'd like to do is divide it into what the nih study told us and what we still don't know.

Data , We-saw , Dr , Booster-shot-confusion , Meet-the-press , Rochelle-walensky , Nih-on-mix , One , Vaccines , Antibody-levels , Matching , Mixing

Alex Witt Reports-20211024-18:42:00

the nih study was simply what we call an immunogenicitiy study which means they took all these different combinations of primary vaccines and then boost it with all three of the vaccines. and what we found was is that if you mixed and matched, you got the same or better antibody response at two weeks. what we don't know, however, and this is the key thing, is whether or not those higher antibodies measured at two weeks actually translates into better protection, better effectiveness, overall and how durable that is. i've heard a lot of different experts now from folks at johnson & johnson but independent experts who've repeatedly said that the johnson & johnson vaccine is not this antibody vaccine the way the mrna vaccines generate these neutralizing antibodies that we talk about obviously incessantly since the vaccinations first rolled out but that the protection from johnson & johnson very much relies on that t-cell immunity, which is not something that we're measuring. so the short answer is that if

Vaccines , Nih-study , Immunogenicitiy , Three , Combinations , Thing , Antibodies , Protection , Effectiveness , We-dont-know , Antibody-response , Two

Early Start With Christine Romans and Laura Jarrett-20211019-09:34:00

poised to approve mix and match booster shots as soon as this week. that is according to "the new york times". and a new study shows recipients of the j&j single-dose shot who later received a moderna booster saw their antibody levels rise 76-fold in 15 days. where as it only rose four fold with a second j&j dose. let's bring in dr. chris pur pernell, fellow at the american college of medicine to dig through it all. >> good morning, doctor. >> good morning. >> mixing and matching these vaccine boosters, it's one of the hot topics right now. if it actually makes -- your first or second shot more effective, should we all be running out and getting a different brand for our third shot when our time comes? good morning. this is fascinating development. this is good science happening in real-time. what we actually see from the n.i.h. study is real-world practicality, meaning that if you were inoculated with moderna

Shot , Recipients , Study , Moderna , Booster-shots , Antibody-levels , The-new-york-times , Booster-saw , Single , J , Fda , Us-

New Day With John Berman and Brianna Keilar-20211019-12:31:00

only 3% nationwide, have already received a booster. with this news, tens of millions more will become eligible to for their extra shot. joining me now is dr. ashish jha, dean of brown university school of public health. dr. jha, thank you for joining us as always. you've been predicting that most americans will end up getting a booster shot. but by early next year. so could this mixing and matching of the vaccine speed up that timeline big time? >> good morning. thank you for having me back. yeah, first and foremost, i think people who are older, people who are chronically ill, they need a booster. and whether you got a moderna, pfizer, j&j, doesn't matter, you need a booster and you should get one. the mixing and matching thing says it doesn't matter which booster you get. if you have the moderna shot before, you can get another mod moderna, pfizer. it is fine. i do think this will speed this up. high risk people should be getting boosters now. i expect lower risk people to be getting a booster maybe later this year or early next year. >> the new york times reporting that an nih study presented last

Booster , Ashish-jha , Dr , United-states , Tens-of-millions , School-of-public-health , Shot , News , Brown-university , 3 , People , Vaccine

CNN Newsroom Live-20211018-06:24:00

that because studies are showing that six or seven months after, you know, the -- the people that have gotten the j&j vaccine, their protection may be down to 3%. maybe, in the single digits. and people are saying well, you know, those vaccines don't work. and the correct response is, wow, look how great science is that they are able to get us this information so quickly so that we can do something about it. so, yes, the recommendation by the fda panel is that anyone who has had a johnson & johnson vaccine at least two months ago will require another booster. anyone of any age of any disease state, immune compromised or not. >> and, doctor, an nih study shows that mixing and matching booster shots could be effective. so, would it make better sense perhaps for recipients of the first j&j shot to get a moderna or pfizer booster, instead of the j&j option? >> well, you know what? that -- the -- the final verdict on that is still out.

People , Vaccine , Studies , Protection , Johnson , Digits , 3 , Seven , Six , Something , Information , Recommendation

CNN Newsroom Live-20211018-07:24:00

>> my first reaction is studies are showing 6 or 7 months after the people that have gotten the j&j vaccine, their protection may be down to 3%, maybe in the single digits. people are saying those vaccines don't work. the correct response is, wow, look how great science is that they're able to get us this information so quickly so that we can do something about it. so, yes, the recommendation by the fda panel is anyone who has had a booster. >> doctor, an nih study shows that mixing and matching booster shots could be effective so would it make better sense, perhaps, for recipients of the first j&j shot to get a moderna

People , Vaccine , Studies , Reaction , J , Protection , 7 , 6 , 3 , Something , Information , Science

Early Start With Christine Romans and Laura Jarrett-20211015-09:32:00

vaccine booster shots. a recent n.i.h. study finds those vaccinated with johnson & johnson had a stronger antibody response from pfizer or moderna's booster. the fda adviser expected to consider a j&j booster today after giving moderna the nod on its booster yesterday. advisers recommended a half dose for people who got their second moderna shot at least six months ago and like pfizer for now, this is just for older patients or people in high-risk jobs. the cdc still needs to give final authorization. shots could begin at the end of next week. time for a three questions in maybe three minutes. let's bring in rob davidson, an e.r. physician in western michigan and executive director of the committee to protect health care. doctor, good morning to you. let's start here on the booster front. the fda is green lighting moderna's vaccine. that's great. but we know that people aren't showing up in your e.r. because they didn't get their third shot. they land in your e.r. because they didn't get their first shot. so, from a public health

Booster , Vaccine-booster-shots , Adviser , Antibody-response , Nih-study , Giving-moderna , Fda , Johnson , Pfizer , People , Patients , Half-dose